Navigation Links
Dendreon Announces Pricing of Common Stock Offering
Date:12/10/2009

and Exchange Commission (the "SEC"). Copies of the prospectus supplement and related base prospectus for this offering, when available, may be obtained by contacting: J.P. Morgan Securities Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, or by calling 1-866-803-9204; or Deutsche Bank Securities Inc., Prospectus Department, Harborside Financial Center, 100 Plaza One, Jersey City, New Jersey 07311-3988, or by calling 1-800-503-4611. An electronic copy of the prospectus supplement and related base prospectus for the offering will also be available on the SEC's website, www.sec.gov.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The offering of these securities will be made only by means of a prospectus supplement and accompanying base prospectus. The securities being offered have not been approved or disapproved by any regulatory authority, nor has any such authority passed upon the accuracy or adequacy of the registration statement or the prospectus contained therein.

About Dendreon

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics. Dendreon applies its expertise in antigen identification, engineering and cell processing to produce ACI product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets TRPM8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. Dendreon has its headquarters in Seattle, Washington, and is traded on the Nasdaq Global Market under the symbol DNDN.

This news release contains forward-looking statements that are subject to risks
'/>"/>

SOURCE Dendreon Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Dendreon Appoints Hans Bishop as Chief Operating Officer
2. Dendreon Announces Proposed Public Offering of Common Stock
3. Dendreon Receives FDA Acknowledgement of Complete Response
4. Dendreon Reports Third Quarter 2009 Financial Results and Continuing Progress Toward PROVENGE Commercialization
5. Dendreon Completes Submission of Biologics License Application for PROVENGE
6. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
7. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
8. Dendreon Announces Analyst Day Webcast Presentation to be Held on September 24, 2009
9. Dendreon Reports Second Quarter 2009 Financial Results
10. Dendreon Signs Lease for New Manufacturing Facility in Atlanta
11. Dendreon to Hold Conference Call on Tuesday, August 11, 2009 at 11:30 AM ET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... MAR, Calif. , Sept. 30, 2014 ... for women,s health announces its receipt of a patent ... FemmyCycle menstrual cup has also received FDA clearance in ... Canada, and the CE in Europe. This patent is related ... conjunction with this issuance, the company is releasing FemmyCycle ...
(Date:9/30/2014)... Stamford, CT (PRWEB) September 30, 2014 ... private non-profit funder of Lyme disease research at universities, ... to researchers focused on the identification, treatment and cure ... noted it had received the most applications in its ... year. , “While we were pleased to receive ...
(Date:9/30/2014)... UFP Technologies, a producer of innovative ... introduced a custom insulated shipping container to house ... insulated shipper solves the issue of temperature variations ... BioShell is a universal storage container which protects ... shipping. The insulated shipper keeps frozen BioShells within ...
(Date:9/29/2014)... September 30, 2014 Each year ... injuries require medical attention. In the military, burn ... complications to battlefield medical care. More than 800 ... Afghanistan. Burn wounds heal slowly, remain inflamed and ... excessive, physically debilitating and functionally damaging. While developments ...
Breaking Biology Technology:The FemmyCycle 2Lyme Research Alliance Awards Nearly $600,000 in New Grants 2Lyme Research Alliance Awards Nearly $600,000 in New Grants 3Lyme Research Alliance Awards Nearly $600,000 in New Grants 4UFP Technologies Introduces Insulated Shipping Container For Bulk Drug Transportation 2UFP Technologies Introduces Insulated Shipping Container For Bulk Drug Transportation 3Faster Healing with Fewer Scars 2
... , , SAN CARLOS, Calif., Sept. 21 ... hosting a conference call to discuss today,s announcement of a new partnership for ... (ET)/5:30 a.m. Pacific Time (PT). , , The live audio-only ... posted on the home page of Nektar,s website: http://www.nektar.com . ...
... ... solution to inventory Ultra-low Freezer and Liquid Nitrogen Tank samples and efficiently manage data ... ... Inc. today announced the release of FreezerPro 2010, Frozen sample inventory and information management ...
... the business of developing high-speed electronic components, it pays ... track of them you will need to use dedicated ... UltraFast Innovations GmbH. The new company, which has just ... and the Max Planck Society (MPG), manufactures specialized mirrors ...
Cached Biology Technology:Nektar Therapeutics to Host Conference Call to Discuss Today's Announcement of a New Partnership for NKTR-118 and NKTR-119 2RURO Inc. Today Announced the Release of FreezerPro 2010, Frozen Sample Inventory and Information Management System 2Optics made to measure 2Optics made to measure 3
(Date:9/30/2014)... Munich report that a new class of chemical ... drugs. They have also pinpointed the relevant target ... agents. , Researchers led by LMU,s Professor ... Technische Universitt Mnchen have identified a class of ... the fight against malignant tumors. The compound is ...
(Date:9/30/2014)... Sept. 30, 2014  Spectra Automation, a ... the biotech and power generation industries, announced ... Bioprocess Manager, an easy-to-use and cost-effective data ... bioprocess development laboratories. Most ... and analyzer systems. Accessing and consolidating data ...
(Date:9/29/2014)... A species of gut bacteria called Clostridium ramosum , ... weight. The work is published this week in mBio ... Microbiology. , A research team from the German Institute ... human gut bacteria including C. ramosum gained weight ... C. ramosum were less obese even when consuming ...
Breaking Biology News(10 mins):Cancer therapy: Driving cancer cells to suicide 2Spectra Automation Introduces RECONN Bioprocess Manager 2Gut bacteria promote obesity in mice 2
... WASHINGTON, DC February 5, 2013 What do microbes have ... is yeast a microbe and every step in the ... freely-available report; FAQ: If the Yeast Ain,t Happy, Ain,t Nobody Happy: ... beer. "Every time someone brews a batch of beer, in ...
... with sexually transmitted infections aren,t getting the treatment they ... new Michigan State University study that highlights a wholly ... current medical guidelines. About half of the 735 ... at three hospitals in Grand Rapids, Mich. from 2008 ...
... The Federation of American Societies for Experimental Biology (FASEB) ... advocacy competition, Stand Up for Science. The competition solicited ... health, quality of life, or economy of local communities ... by ,Stand With Science, a group of graduate students ...
Cached Biology News:Yeast we can! New report answers questions on microbiology and beer 2Few pregnant women treated for sexually transmitted infections 2
Mouse monoclonal [MLM544] to cardiac Myosin light chain 1 ( Abpromise for all tested applications). entrezGeneID: 4634 SwissProtID: P08590...
Request Info...
Anti-20S proteasome subunits alpha 1, 2, 3, 5, 6 & 7, clone MCP231 Immunogen: Dinitrophenylated proteasomes Molecular Weight: 29 and 32 kDa....
Mouse monoclonal [J53] to Thyroid Hormone Receptor beta 1 ( Abpromise for all tested applications). entrezGeneID: 7068 SwissProtID: P10828...
Biology Products: